Silvia Boschi

Turin, 10126, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Role of the Clock Drawing Test in Differential Diagnosis of Alzheimer's Disease: Clinical Findings in Relation to CSF Biomarkers.

Role of the Clock Drawing Test in Differential Diagnosis of Alzheimer's Disease: Clinical Findings in Relation to CSF Biomarkers.

Journal: International journal of molecular sciences
Published: January 22, 2026

Plasma p-tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach.

Plasma p-tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: November 20, 2025

UCH-L1 in Alzheimer's Disease: A Crucial Player in Dementia-Associated Mechanisms.

UCH-L1 in Alzheimer's Disease: A Crucial Player in Dementia-Associated Mechanisms.

Journal: International journal of molecular sciences
Published: August 18, 2025

Metabolic syndrome and dementia: Independent risk factors or a unified pathway?

Metabolic syndrome and dementia: Independent risk factors or a unified pathway?

Journal: Journal of Alzheimer's disease : JAD
Published: July 18, 2025

Exploring Frailty Status and Blood Biomarkers: A Multidimensional Approach to Alzheimer's Diagnosis.

Exploring Frailty Status and Blood Biomarkers: A Multidimensional Approach to Alzheimer's Diagnosis.

Journal: Geriatrics (Basel, Switzerland)
Published: July 14, 2025

Comparison of Simoa and Lumipulse Neurofilament Light Chain Measurements in Alzheimer's Cerebrospinal Fluid: Preliminary Findings.

Comparison of Simoa and Lumipulse Neurofilament Light Chain Measurements in Alzheimer's Cerebrospinal Fluid: Preliminary Findings.

Journal: Brain sciences
Published: July 01, 2025

The Role of Blood-Based Biomarkers in Transforming Alzheimer's Disease Research and Clinical Management: A Review.

The Role of Blood-Based Biomarkers in Transforming Alzheimer's Disease Research and Clinical Management: A Review.

Journal: International journal of molecular sciences
Published: July 01, 2025

Corrigendum to "Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study" [Heliyon Volume 8, Issue 11, November 2022, Article e11738].

Corrigendum to "Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study" [Heliyon Volume 8, Issue 11, November 2022, Article e11738].

Journal: Heliyon
Published: June 19, 2025

Iron Overload, Microbleeding and the Role of Bilirubin in Alzheimer's Disease Brain: Revisiting the Vascular Hypothesis.

Iron Overload, Microbleeding and the Role of Bilirubin in Alzheimer's Disease Brain: Revisiting the Vascular Hypothesis.

Journal: International journal of molecular sciences
Published: February 19, 2025

Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.

Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.

Journal: Journal of Alzheimer's disease : JAD
Published: January 27, 2025

Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease.

Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease.

Journal: Alzheimer's research & therapy
Published: July 10, 2024

Correction to: Cognitive dysfunction, social behavior disorder, cerebellar ataxia, and atypical brain FDG‑PET presentation in spinocerebellar ataxia 17: a case report.

Correction to: Cognitive dysfunction, social behavior disorder, cerebellar ataxia, and atypical brain FDG‑PET presentation in spinocerebellar ataxia 17: a case report.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 28, 2024
Showing 1-12 of 49

Last Updated: 09/26/2026